Back
uniQure NV Vs. Pharming Group Industry Stock Comparison
Sell
11
QURE
uniQure NV
Last Price:
5.46
Seasonality Move:
11.25%
Buy
53
PHAR
Pharming Group
Last Price:
7.71
Seasonality Move:
-7.8%
Sell
11
uniQure NV (QURE)
is a Sell
Is uniQure NV a Buy, Sell or Hold?
- The current uniQure NV [QURE] share price is $5.65. The Score for QURE is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- QURE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
53
Pharming Group (PHAR)
is a Buy
Is Pharming Group a Buy, Sell or Hold?
- The current Pharming Group [PHAR] share price is $8.04. The Score for PHAR is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
- PHAR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
QURE Stock Price Chart
What is uniQure NV's stock price today?
-
The uniQure NV share price today is $5.65
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QURE is experiencing selling pressure, which indicates risk of future bearish movement.
PHAR Stock Price Chart
What is Pharming Group's stock price today?
-
The Pharming Group share price today is $8.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAR is experiencing buying pressure, which is a positive indicator for future bullish movement.
QURE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.29 | Sell |
Relative Strength Index (14 RSI): | 42.92 | Sell |
Chaikin Money Flow: | -389324 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.43 - 6.45) | Sell |
Bollinger Bands (100): | (4.49 - 7.31) | Sell |
PHAR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 56.59 | Buy |
Chaikin Money Flow: | 4474 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.32 - 7.98) | Buy |
Bollinger Bands (100): | (7.58 - 9.18) | Sell |
QURE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.55 | Buy |
20-day SMA: | 5.74 | Sell |
50-day SMA: | 6.89 | Sell |
200-day SMA: | 5.86 | Sell |
8-day EMA: | 5.61 | Buy |
20-day EMA: | 5.83 | Sell |
50-day EMA: | 6.15 | Sell |
200-day EMA: | 6.73 | Sell |
PHAR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.61 | Buy |
20-day SMA: | 7.59 | Buy |
50-day SMA: | 7.89 | Buy |
200-day SMA: | 9.93 | Sell |
8-day EMA: | 7.73 | Buy |
20-day EMA: | 7.65 | Buy |
50-day EMA: | 7.89 | Buy |
200-day EMA: | 9.41 | Sell |
uniQure NV Earnings Growth & QURE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.44 per share, an increase this year of $2.09 per share, and an increase next year of $1.38 per share.
Pharming Group Earnings Growth & PHAR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.01 per share, and an increase next year of $0.03 per share.
uniQure NV Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Pharming Group Technical Analysis
Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |